Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership290,841 shares
Latest Disclosed Value $ 1,308,786
Invesco Ltd. reports 42.66% decrease in ownership of MYGN / Myriad Genetics, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 290,841 shares of Myriad Genetics, Inc. (US:MYGN) valued at $1,308,784 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 507,180 shares of Myriad Genetics, Inc.. This represents a change in shares of -42.66% during the quarter. The current value of the position is $1,330,598 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F MYRIAD GENETICS COM 62855J104 290,841 -216,339 -42.66 1,309 -58.06 0.0000
2026-02-19 2025-12-31 13F MYRIAD GENETICS COM 62855J104 507,180 12,026 2.43 3,119 -12.85 0.0005
2025-11-13 2025-09-30 13F MYRIAD GENETICS COM 62855J104 495,154 6,104 1.25 3,580 37.87 0.0006
2025-08-13 2025-06-30 13F MYRIAD GENETICS COM 62855J104 489,050 -427,470 -46.64 2,597 -68.06 0.0004
2025-05-12 2025-03-31 13F MYRIAD GENETICS COM 62855J104 916,520 147,236 19.14 8,130 -22.92 0.0015
2025-02-13 2024-12-31 13F MYRIAD GENETICS COM 62855J104 769,284 211,503 37.92 10,547 -30.97 0.0019
2024-11-12 2024-09-30 13F MYRIAD GENETICS COM 62855J104 557,781 -50,666 -8.33 15,278 2.65 0.0029
2024-08-13 2024-06-30 13F MYRIAD GENETICS COM 62855J104 608,447 -2,206 -0.36 14,883 14.31 0.0031
2024-05-14 2024-03-31 13F MYRIAD GENETICS COM 62855J104 610,653 -92,767 -13.19 13,019 -3.30 0.0028
2024-02-13 2023-12-31 13F MYRIAD GENETICS COM 62855J104 703,420 -54,156 -7.15 13,463 10.80 0.0032
2023-11-13 2023-09-30 13F MYRIAD GENETICS COM 62855J104 757,576 47,620 6.71 12,152 -26.16 0.0033
2023-08-11 2023-06-30 13F MYRIAD GENETICS COM 62855J104 709,956 286,785 67.77 16,457 67.41 0.0043
2023-05-12 2023-03-31 13F MYRIAD GENETICS COM 62855J104 423,171 -384,570 -47.61 9,830 -16.13 0.0027
2023-02-13 2022-12-31 13F MYRIAD GENETICS COM 62855J104 807,741 378,134 88.02 11,720 43.00 0.0034
2022-11-14 2022-09-30 13F MYRIAD GENETICS COM 62855J104 429,607 -13,378 -3.02 8,196 1.83 0.0026
2022-08-15 2022-06-30 13F MYRIAD GENETICS COM 62855J104 442,985 -216,807 -32.86 8,049 -51.59 0.0024
2022-05-16 2022-03-31 13F MYRIAD GENETICS COM 62855J104 659,792 -130,960 -16.56 16,626 -23.82 0.0042
2022-02-14 2021-12-31 13F MYRIAD GENETICS COM 62855J104 790,752 -15,473 -1.92 21,825 -16.16 0.0053
2021-11-15 2021-09-30 13F MYRIAD GENETICS COM 62855J104 806,225 40,327 5.27 26,032 11.14 0.0066
2021-08-17 2021-06-30 13F MYRIAD GENETICS COM 62855J104 765,898 -215,403 -21.95 23,422 -21.62 0.0058
2021-05-17 2021-03-31 13F MYRIAD GENETICS COM 62855J104 981,301 478,591 95.20 29,881 200.58 0.0080
2021-02-16 2020-12-31 13F MYRIAD GENETICS COM 62855J104 502,710 1,892 0.38 9,941 52.24 0.0029
2020-11-16 2020-09-30 13F MYRIAD GENETICS COM 62855J104 500,818 -453,961 -47.55 6,530 -39.69 0.0022
2020-08-14 2020-06-30 13F MYRIAD GENETICS COM 62855J104 954,779 90,607 10.48 10,827 -12.45 0.0039
2020-05-15 2020-03-31 13F MYRIAD GENETICS COM 62855J104 864,172 365,365 73.25 12,367 -8.95 0.0052
2020-02-14 2019-12-31 13F MYRIAD GENETICS COM 62855J104 498,807 -1,278,540 -71.94 13,583 -73.31 0.0042
2019-11-14 2019-09-30 13F MYRIAD GENETICS COM 62855J104 1,777,347 -78,786 -4.24 50,886 -1.31 0.0133
2019-08-14 2019-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 1,856,133 305,143 19.67 51,563 0.14 0.0133
2019-08-14 2019-06-30 13F MYRIAD GENETICS COM 62855J104 1,856,133 -492,380 51,563
2019-05-15 2019-03-31 13F MYRIAD GENETICS COM 62855J104 1,550,990 -93,347 -5.68 51,493 7.73 0.0174
2019-02-14 2018-12-31 13F MYRIAD GENETICS COM 62855J104 1,644,337 213,850 14.95 47,800 -27.36 0.0183
2018-11-14 2018-09-30 13F MYRIAD GENETICS COM 62855J104 1,430,487 405,057 39.50 65,802 71.72 0.0207
2018-08-14 2018-06-30 13F MYRIAD GENETICS COM 62855J104 1,025,430 219,610 27.25 38,320 60.93 0.0127
2018-05-15 2018-03-31 13F MYRIAD GENETICS COM 62855J104 805,820 109,882 15.79 23,811 -0.38 0.0089
2018-02-14 2017-12-31 13F MYRIAD GENETICS COM 62855J104 695,938 205,246 41.83 23,902 34.64 0.0086
2017-11-14 2017-09-30 13F MYRIAD GENETICS COM 62855J104 490,692 -85,625 -14.86 17,753 19.21 0.0066
2017-08-14 2017-06-30 13F MYRIAD GENETICS COM 62855J104 576,317 -41,510 -6.72 14,892 25.54 0.0046
2017-05-15 2017-03-31 13F MYRIAD GENETICS COM 62855J104 617,827 157,511 34.22 11,862 54.59 0.0039
2017-02-14 2016-12-31 13F MYRIAD GENETICS COM 62855J104 460,316 52,816 12.96 7,673 -8.51 0.0026
2016-11-14 2016-09-30 13F MYRIAD GENETICS COM 62855J104 407,500 -834,080 -67.18 8,387 -77.93 0.0029
2016-08-15 2016-06-30 13F MYRIAD GENETICS COM 62855J104 1,241,580 -274,058 -18.08 37,994 -33.03 0.0140
2016-05-16 2016-03-31 13F MYRIAD GENETICS COM 62855J104 1,515,638 417,449 38.01 56,731 19.69 0.0231
2016-02-16 2015-12-31 13F MYRIAD GENETICS COM 62855J104 1,098,189 292,203 36.25 47,399 56.90 0.0189
2015-11-16 2015-09-30 13F MYRIAD GENETICS COM 62855J104 805,986 214,915 36.36 30,209 50.36 0.0128
2015-08-14 2015-06-30 13F MYRIAD GENETICS COMMON 62855J104 591,071 -34,312 -5.49 20,091 -9.25 0.0079
2015-05-15 2015-03-31 13F MYRIAD GENETICS COMMON 62855J104 625,383 -141,560 -18.46 22,139 -15.25 0.0086
2015-02-13 2014-12-31 13F MYRIAD GENETICS COMMON 62855J104 766,943 -247,902 -24.43 26,123 -33.26 0.0101
2014-11-14 2014-09-30 13F MYRIAD GENETICS COMMON 62855J104 1,014,845 -188,327 -15.65 39,142 -16.41 0.0156
2014-08-14 2014-06-30 13F MYRIAD GENETICS COMMON 62855J104 1,203,172 7,901 0.66 46,828 14.59 0.0184
2014-05-15 2014-03-31 13F MYRIAD GENETICS COMMON 62855J104 1,195,271 242,450 25.45 40,866 104.44 0.0166
2014-02-13 2013-12-31 13F MYRIAD GENETICS COMMON 62855J104 952,821 206,616 27.69 19,989 13.99 0.0079
2013-11-13 2013-09-30 13F MYRIAD GENETICS COMMON 62855J104 746,205 259,867 53.43 17,535 34.19 0.0076
2013-08-14 2013-06-30 13F MYRIAD GENETICS COMMON 62855J104 486,338 486,338 13,067 0.0061
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.